drugset / Trial / NCT02819297

BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

NCT02819297

Phase 3 Completed 1020 enrolled Braintree Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus placebo in constipated adults.

Timeline

Start
2016-06
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactitol Small molecule 21 g

Indications